title: PI3K/AKT inhibitors in patients with refractory renal cell carcinoma: what have we learnt so far?
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, USA.
authors.forename: P J
authors.initials: PJ
authors.lastname: Vlachostergios
authors.affiliation: Division of Hematology and Medical Oncology, Department of Medicine, Meyer Cancer Center, Weill Cornell Medicine, New York, USA.
authors.forename: A M
authors.initials: AM
authors.lastname: Molina
mesh_terms: D002292:Carcinoma, Renal Cell; D045744:Cell Line, Tumor; D006801:Humans; D007680:Kidney Neoplasms; D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt
chemical_list: D019869:Phosphatidylinositol 3-Kinases; D051057:Proto-Oncogene Proteins c-akt